These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 29207971)

  • 1. Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    Ko H; Shin J; Lee JE; Nam SJ; Nguyen TL; Hopper JL; Song YM
    BMC Cancer; 2017 Dec; 17(1):821. PubMed ID: 29207971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
    Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
    Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
    Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
    J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort.
    Gill JK; Maskarinec G; Pagano I; Kolonel LN
    Breast Cancer Res; 2006; 8(3):R30. PubMed ID: 16796758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
    Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
    J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS).
    Gooch JC; Chun J; Kaplowitz E; Kurz E; Guth A; Lee J; Schnabel F
    Ann Surg Oncol; 2019 Oct; 26(11):3472-3477. PubMed ID: 31147991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?
    Ouldamer L; Lechaux E; Arbion F; Body G; Vildé A
    Breast; 2014 Dec; 23(6):889-93. PubMed ID: 25456102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
    Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia.
    Papantoniou V; Valsamaki P; Sotiropoulou E; Tsaroucha A; Tsiouris S; Sotiropoulou M; Marinopoulos S; Kounadi E; Karianos T; Fothiadaki A; Archontaki A; Syrgiannis K; Ptohis N; Makris N; Limouris G; Antsaklis A
    Mol Imaging; 2011 Oct; 10(5):370-6. PubMed ID: 21521552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
    Park GE; Kim SH; Kim EJ; Kang BJ; Park MS
    Acta Radiol; 2017 Nov; 58(11):1294-1302. PubMed ID: 28273747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
    Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
    Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
    Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
    Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
    Jiang L; Ma T; Moran MS; Kong X; Li X; Haffty BG; Yang Q
    Anticancer Res; 2011 Jun; 31(6):2327-34. PubMed ID: 21737659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.